Delivery Order SPE2DB20D7059-SPE2DB25FGRS1
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $8,274.97 to AmerisourceBergen Drug Corp for PREVNAR 20 Syringe 0.5ML, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. PREVNAR 20 is a pneumococcal conjugate vaccine used to prevent pneumococcal disease, supporting the federal government's medical supply...
- The Defense Logistics Agency awarded a delivery order valued at $8,453.56 to AmerisourceBergen Drug Corp for PREVNAR 20 syringes (0.5ML) on August 27, 2025, with an ultimate completion date of August 28, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. PREVNAR 20 is a pneumococcal conjugate vaccine used for immunization against pneumococcal...
- The Defense Logistics Agency awarded a $12,261.63 firm fixed price delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 syringes (0.5mL) on August 12, 2025, with an ultimate completion date of August 13, 2025. This is a non-set-aside contract, competitively awarded to the pharmaceutical distributor's Corporate Office division located in Conshohocken, Pennsylvania. PREVNAR 20 is a pneumococcal conjugate vaccine used to prevent pneumococcal disease in eligible populations, representing...
- The Defense Logistics Agency awarded a $14,078.16 delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 syringes (0.5mL) on July 30, 2025, with a completion date of July 31, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. PREVNAR 20 is a pneumococcal conjugate vaccine used to prevent pneumococcal disease across multiple age groups, making it...
- The Defense Logistics Agency awarded a delivery order valued at $24,506.55 to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 syringes (0.5mL) on July 24, 2025, with an ultimate completion date of July 25, 2025. This delivery order represents a competitive, firm fixed-price award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. PREVNAR 20 is a pneumococcal conjugate vaccine used for immunization against pneumococcal disease,...
- The Defense Logistics Agency awarded a delivery order valued at $27,354.93 to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 syringes (0.5mL) on August 28, 2025, with an ultimate completion date of August 29, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. PREVNAR 20 is a pneumococcal vaccine critical to military and federal healthcare immunization...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 vaccine in pre-filled syringes (0.5mL) with a ceiling value of $14,921.11. This firm fixed-price, competitively awarded contract was issued on August 18, 2025, with an ultimate completion date of August 19, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at approximately $25,018 to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 vaccine in 0.5mL syringes. This non-set-aside, competitively awarded contract reflects a firm fixed-price arrangement with an ultimate completion date of August 28, 2025. The delivery order was executed on August 27, 2025, with performance to be fulfilled at AmerisourceBergen's Conshohocken, Pennsylvania location. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $20,520.05 to AmerisourceBergen Drug Corp for PREVNAR 20 syringes (0.5 mL) on August 19, 2025, with completion scheduled for August 20, 2025. This competitively awarded, firm fixed price contract involves no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. PREVNAR 20 is a pneumococcal conjugate vaccine used to prevent pneumococcal disease, reflecting the...
- The Defense Logistics Agency awarded a delivery order valued at $4,901.31 to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 syringes (0.5mL) on August 28, 2025, with completion scheduled for August 29, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. PREVNAR 20 is a pneumococcal conjugate vaccine used to protect against pneumococcal...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB25FGRS1Delivery Order
The Defense Logistics Agency awarded a $3,267.56 delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 vaccine in syringe form (0.5mL units) on September 13, 2025, with an ultimate completion date of September 15, 2025. This competitively awarded, firm fixed-price contract is non-set-aside and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. PREVNAR 20 is a pneumococcal conjugate vaccine used to prevent pneumococcal disease and represents a critical pharmaceutical commodity within the military healthcare supply chain. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999 ceiling value and extends through December 2026. As a prime contractor on this comprehensive global pharmaceutical support vehicle, AmerisourceBergen supplies a broad range of pharmaceutical products, vaccines, and medical supplies to support Defense Health Agency and other federal healthcare systems worldwide. The company's substantial IDC demonstrates its established capability to efficiently fulfill federal medical procurement requirements across multiple therapeutic domains and product categories.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 9/13/25 |